Pharma Intelligence Podcast public
[search 0]
More
Download the App!
show episodes
 
Discover the transformative power of GenAI, Data Analytics, Social Intelligence, and Physician Influencer Marketing that is shaping the future of pharma marketing. Join us, as we pave the pathway to a novel pharma marketing landscape, bringing to you conversations that meet at the intersection of technology and marketing. Hosted by Saumya Prakash, Co-Founder Multiplier AI Solutions, this podcast is spearheading the dialogues on disruptions in pharma marketing. Know more about us at: https:// ...
  continue reading
 
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
  continue reading
 
Artwork
 
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
  continue reading
 
Artwork

1
Digital Pathology Podcast

Aleksandra Zuraw, DVM, PhD

Unsubscribe
Unsubscribe
Monthly+
 
Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.
  continue reading
 
Welcome to 'Controversial as Fuck' with Hollie Wild, where thought leaders and industry changers converge to amplify voices often silenced and tackle the taboo. Each episode delves into the tough discussions surrounding big pharma, mainstream media, social justice movements, and beyond, grilling the sacred cows of our time. This isn't just a podcast—it's a revolution for those who dare to think differently, engage in conversations that drive real change, and inspire resilience across mental, ...
  continue reading
 
Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com
  continue reading
 
A weekly podcast discussion about asymmetric learning - how organisations gain competitive advantage through their approach to learning, in all its forms. We will talk with thought leaders and experts to understand processes and systems of learning that lead to outperformance.
  continue reading
 
There is an old saying ” You can have all kinds of time and money, but if you have poor health, you’ll never be able to enjoy it.” Join your host, Jeanne Olson as she uncovers the secrets of ingredient intelligence, guiding you from bad to good choices for more vibrant health and longevity so you CAN enjoy life! This is a podcast that delves into the world of ingredients found in everyday products, offering valuable insights to help you make healthier choices. In each episode, she spotlights ...
  continue reading
 
Intelligent Automation – a powerful confluence of Process Intelligence, Intelligent Document Processing, RPA, Low Code/No Code application development, and Intelligent Virtual Agents, built on a stack of Advanced Intelligence capabilities, powered by Generative AI and supported by Next-gen Infrastructure. It empowers enterprises to drive integrated human experience outcomes, powered by agile configurable workflows.
  continue reading
 
Artwork
 
The EAST Podcast aims to bring technology closer to your senses. Know how every single piece of technology in todays world affects you. Whether it’s enterprise technology like Servers, Data Centres, or coding for Mobile Apps, or websites, or Concepts like Artificial Intelligence, 3D printing, Robotics – we will try to make it simpler for you. We will also tackle driverless cars, new consumer technologies, and sometimes, even a new consumer product.
  continue reading
 
Science Will Win is a podcast that takes listeners under the microscope of some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating scie ...
  continue reading
 
HappCo CEO and founder Dr. Zach is on a mission to raise the emotional intelligence of society through guided meditation. A meditative practice is essential to living life to the fullest. That's why the HappCo "Embracing Your Higher Self" guided meditation program is for everyone. Each podcast episode delves deeper into the key competencies explored in Zach's book, which also serves as a companion guide to the mobile app. Zach was an eye doctor for ten years and then a healthcare venture cap ...
  continue reading
 
Loading …
show series
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.J&J has acquired heart failure implant maker V-Wave for up to $1.7 billion, while Medtronic reiterates its unchanged diabetes strategy despite a partnership with Abbott. Histosonics secured $102 million for a noninvasive …
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by IdentifAI founders Justin Marciano and Paul Vann to explore the deep fake challenge and the innovative solutions they are developing. The pair share their unique backgrounds and motivations for founding the company, emphasising the critical need to address the growing threat of …
  continue reading
 
Explore the dynamic shift from traditional to digital marketing strategies in the pharmaceutical sector that is being triggered and drive by GenAI. Join us for a fascinating conversation with Dr. Kavita Lamror, a leading expert in real-world evidence and digital transformation at Maxis Clinical Sciences. In this episode, Dr. Kavita delves into how …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.On August 19, 2024, the FDA approved the first at-home syphilis test by NowDiagnostics, providing quick results with just a drop of blood. Dupont acquired Donatelle Plastics for $313 million, while Boston Scientific resub…
  continue reading
 
Dive into an unfiltered conversation with powerhouse Holly Loxton as we explore trauma, healing, and the transformative power of psychedelics. We'll challenge the concept of the patriarchy and dissect its impact on our lives. Prepare for thought-provoking discussions on politics, religion, and the New Age movement, all with a focus on questioning e…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Medicare has revealed the results of drug price negotiations, showing $6 billion in savings for taxpayers from talks involving drugs like Eliquis and Xarelto. Lilly has opened an R&D hub in Boston, while Ovid and Lexicon ar…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 August 2024. In this episode: Merck & Co. steps into CD19 bispecific space; gene therapy patients rise, but slowly; Madrigal’s Rezdiffra plans; Korean biopharma financing recovering?; and approvals to watch out for in Q3.https://scrip.citeline.com/SC1507…
  continue reading
 
Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains outstanding.More On These Topics From The Pink SheetMedicare Negotiation Announcement: Discounts From List Price Up To 79%, But Net Savings Unclear: https://pink.citeline.com/PS155128/Medicare-Negoti…
  continue reading
 
Dive into an inspiring chat with Steve Lindsey, CEO of Garden Spot Village, where we explore the transformative power of purpose in senior living. Discover how purpose, engagement, and community culture redefine experiences for both staff and residents. Learn about cross-generational connections and the evolution of a thriving organization. Get rea…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Evotec is exiting the gene therapy field and cutting jobs due to a slowdown in research spending. Merck has made a $700 million bet on an antibody drug for immune diseases, while Lilly has opened a new R&D hub in Boston. Ov…
  continue reading
 
0:00 Intro to The Genetics Podcast 01:00 Welcome to Scott 01:55 Scott’s career highlights to date, ranging from epidemiology to the genetics of asthma and chronic obstructive pulmonary disease (COPD) 04:56 How and why Scott decided to transition into genetics 06:30 The advances in our understanding of the genetics of asthma and COPD over the past 2…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The FDA recently approved Ascendis' drug for a rare endocrine condition, while rejecting MDMA as a therapy aid for PTSD. Pfizer also presented data supporting a case for an RSV shot for immunocompromised adults. Zepbound sh…
  continue reading
 
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちらWhat To Look Out For At ESC 2024https://scrip.citeline.com/SC150740/What-To-Look-Out-For-At-ESC-2024By Citeline
  continue reading
 
Welcome to Ingredient Intel, where Jeanne Olson, your dedicated ingredient investigator, dives deep into the world of health-related products. In this episode, Jeanne is thrilled to welcome Jason Bronstad, CEO of Malk Organics, to share his compelling health journey and insights into the world of plant-based milks. Jason opens up about his personal…
  continue reading
 
In this fast-paced episode of Comment Chaos, I tackle TikTok censorship, dissect the latest social media uproars, and dive into the cultural clashes stirring up heated debates. From the struggles of free speech online to the chaos that ignites across platforms, this episode unpacks the challenges that come with sharing bold opinions in a highly cha…
  continue reading
 
Compliance with environmental sustainability goals is no longer optional for medtech companies serving global healthcare markets. Thermo Fisher has made it a mission to be a leader in thought and actions in meeting Scope 1, 2 and 3 needs. Corporate VP and head of sustainability Meron Mathias explains the company's sustainability aims and methods, f…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Steward, a bankrupt healthcare organization, is set to sell its physician group to a private equity firm for $245 million. Kaiser's operating margin has risen to 3.1% in the second quarter, indicating a strong performance …
  continue reading
 
Can you imagine how exclusivity showcased the critical importance of adaptable strategies in the pharmaceutical industry? In this episode, embark on an illuminating journey through the evolution of pharmaceutical marketing as your host Soumya Prakash engages in a thought-provoking dialogue with industry luminary Salil Kallianpur. In this podcast Mr…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Vinoth Nageshwaran, a leading data engineer currently working at Business Insider. Vinoth discusses the challenges of large language models (LLMs) like ChatGPT, which often hallucinate or generate inaccurate information due to their lack of true understanding and ability to veri…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA approved Ascendis' drug for a rare endocrine condition, while rejecting MDMA as a therapy aid for PTSD. Pfizer presented new data on their RSV shot for immunocompromised adults. Halda, a startup, raised $126 milli…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 August 2024. In this episode: Amgen positions for obesity and diabetes; BMS returns TIGIT asset in pipeline reshuffle; is Kerendia the next jewel in Bayer’s crown?; Japan pharma firms cut jobs; and Sun Pharma seeks GLP-1 partner.https://scrip.citeline.com…
  continue reading
 
In this profound episode of 'Controversial as Fuck,' I sit down with James Pask, a metaphysical teacher and healing facilitator, to delve deep into spiritual intelligence and the journey of self-discovery. We discuss the transformative power of going within, exploring past lives, karma, universal laws, and the nature of spiritual intelligence. Jame…
  continue reading
 
Since becoming a standalone consumer health company, Haleon has been driving awareness of public health issues such as chronic pain and children’s oral health. In this episode of Over the Counter, HBW Insight catches up with Haleon vice president and general manager Great Britain and Ireland Bas Vorsteveld, to find out more about why having a purpo…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Abbott and Medtronic have announced a partnership to develop diabetes technology, with Abbott creating a glucose sensor that will only connect with Medtronic's insulin delivery technology. Nevro is considering a sale in res…
  continue reading
 
Pink Sheet reporter and editors discuss former Surgeon General Jerome Adams’ views on how the FDA can better ensure clinical trial diversity (:27), questions about approving a new drug that would be used with a standard of care regimen that is off-label (15:00), and the agency beginning to schedule fully in-person advisory committee meetings (24:03…
  continue reading
 
Send us a Text Message. In this episode of DigiPath Digest, broadcasting from Poland, we delve into advances in digital pathology, including AI applications in bone marrow evaluation, classification of hematology cells, and the use of synthetic images for data augmentation. Additionally, we review a survey on pathologists' perceptions of ChatGPT an…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Learn how real-world data (RWD) can be utilized in clinical trials to create more diverse control arms and expedite the process of bringing therapies to market. The FDA's considerations for sponsors using RWD in external …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.This week in biopharma news, Novo's stock experienced a sell-off due to lower-than-expected obesity drug sales, Madrigal's new drug launch exceeded expectations, and Biomarin is focusing on narrowing its sales focus for its…
  continue reading
 
0:00 Intro to The Genetics Podcast 01:00 Welcome to Austin 01:42 What is aging and how should we think about it? 03:50 Discussion of Austin’s recent breakthrough paper on aging, including the questions he set out to answer, and the outcomes of the research 06:32 How Austin’s work focuses on using large-scale population proteomics data to create acc…
  continue reading
 
In this episode of 'Comment Chaos,' I dive into the most chaotic, controversial, and insightful comments from my social media platforms. From Instagram to TikTok, I address a viral reel on the feminist movement and a bold stance on gender identity and kids. Join me as I discuss the significance of follower count, the importance of discernment in so…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Small biopharma and contract research organizations are increasingly adopting eClinical technology to keep up with regulatory and market demands for research innovation. They are paying attention to how these tools can help…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Navid Alipour, CEO of CureMetrix, which is a leading AI-powered medical imaging company that specialises in early detection of breast cancer and heart disease. The company has received two historic FDA clearances for its AI-powered breast cancer detection and breast arterial cal…
  continue reading
 
올해 상반기 일라이 릴리와 노보 노디스크의 주가가 가장 높은 상승세를 보인 반면, BMS와 길리어드의 주가는 가장 큰 폭으로 하락했습니다. Scrip의 글로벌 제약주 동향 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150593/Obesity-Rules-Large-Cap-Stocks-In-First-Half-Of-2024By Citeline
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Steward Health plans to lay off over 1,200 workers in Massachusetts and close two hospitals. Walgreens has reduced its stake in Cencora for $1.1 billion. The cost of healthcare data breaches is nearly $10 million in 2024, …
  continue reading
 
Join me on a gripping journey as we delve into the hidden agendas of the CIA, the intricacies of the Cold War, and the feminist movement like never before. In this episode, we explore the potential covert operations and influence of the CIA on social movements, specifically feminism, and ask some thought-provoking questions: How deep do the connect…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pfizer is terminating its Duchenne gene therapy program, resulting in the layoff of 150 staff members. Boehringer has acquired startup Nerio for up to $1.3 billion to expand its cancer drug pipeline. Emerging biotech IPOs…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 August 2024. In this episode: Pfizer bullish on its oral GLP-1; BMS’s rising confidence about Medicare pricing of Eliquis; more long term data for Leqembi; NewAmsterdam’s CETP inhibitor shows promise; and a look at Mankind’s Bharat Serums buy.https://scri…
  continue reading
 
Send us a Text Message. Exploring Foundation Models in Digital Pathology: Insights and Tools In today's DigiPath Digest we talk about the foundation models in pathology. reviewing abstracts from two notable papers in Nature. We discuss the high-level overview of these models, including Hamid Tizhoosh's insights on the vast data requirements for dev…
  continue reading
 
Pink Sheet reporter and editors discuss the US FDA drug approval decisions that could arrive in August (:34), a trial design issue that could ensnare BMS’ Opdivo along with AstraZeneca’s Imfinzi (10:11), and the EMA potentially asking all sponsors to provide raw clinical data as part of application reviews (33:14).More On These Topics From The Pink…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The CEO of 23andme, Anne Wojcicki, has proposed to take the company private by buying shares at 40 cents each. GE Healthcare is facing pressure in China as hospitals delay orders, impacting revenue growth for Johnson & Joh…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. GSK's vaccine sales are slowing down, while Merck's Gardasil sales dropped in China, leading to a slide in Merck's shares. Keytruda reached a sales milestone of $7 billion. Leqembi was voted down by European regulators. Br…
  continue reading
 
0:00 Intro to The Genetics Podcast 01:00 Welcome to Daniel 02:04 Defining rare disease in the age of personalized medicine 04:57 Key touchpoints with the Medicines and Healthcare products Regulatory Agency (MHRA) when developing a new medicine 09:27 Improvements over the course of Daniel’s career when it comes to incentivizing and making the path t…
  continue reading
 
Dive into this light-hearted, thought-provoking, and humorous episode of Comment Chaos as we explore the gender debate sparked by a viral YouTube short. Join me as I read through comments, share my perspectives, and respond to various viewpoints on gender and sex. From the importance of feeling comfortable in one's body to the unyielding truths of …
  continue reading
 
COPD expert Wen-Yu discusses what the entrance of biologics might mean for the COPD treatment landscape and shares a sneak peek from her upcoming patient-based forecast.Other platforms (in addition to SoundCloud):​Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836​Google Podcasts - https://podcasts.goo…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The biotech industry is experiencing significant growth, with drugmakers in the U.S. and Europe raising $6.8 billion in venture capital funding in the first three months of the year. This trendline explores the evolving b…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Julien Willard, a Partner and Life Science Lead at IBM. Julien is focused on how AI is being used to tackle global health challenges, particularly in low and middle-income countries (LMICs). Julien & Andree discuss the importance of accounting for local context when implementing…
  continue reading
 
Welcome to Ingredient Intel, where your ingredient investigator uncovers the truth behind what’s in your food and products. In this episode, we dive into the tangy world of dill pickles and their juice. Our host, with over 30 years of experience in health education and personal training, shares a fascinating childhood story about a pickle juice clu…
  continue reading
 
Loading …

Quick Reference Guide